Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Severance Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: -

Market Cap: -

Website: http://www.yuhs.or.kr/en/hospitals/severance/sev_intro/gnr_info

Clinical Trials

The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients

Not Applicable

Completed

Conditions: Anesthesia Recovery Period, Neuromuscular Blockade

Interventions: Drug: Sugammadex

First Posted Date: 2013-07-01

Last Posted Date: 2014-02-04

Lead Sponsor: Severance Hospital

Target Recruit Count: 44

Registration Number: NCT01890057

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients

Not Applicable

Completed

Conditions: Intubation, Intratracheal

Interventions: Drug: Remifentanil

First Posted Date: 2013-06-19

Last Posted Date: 2015-04-09

Lead Sponsor: Severance Hospital

Target Recruit Count: 44

Registration Number: NCT01880931

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Rosuvastatin
Drug: Olmesartan
Drug: Rosuvastatin and olmesartan

First Posted Date: 2013-04-15

Last Posted Date: 2013-04-15

Lead Sponsor: Severance Hospital

Target Recruit Count: 36

Registration Number: NCT01831479

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Test formulation
Drug: Reference formulation

First Posted Date: 2013-04-04

Last Posted Date: 2013-04-11

Lead Sponsor: Severance Hospital

Target Recruit Count: 50

Registration Number: NCT01823913

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Test formulation
Drug: Reference formulation

First Posted Date: 2013-04-04

Last Posted Date: 2013-04-11

Lead Sponsor: Severance Hospital

Target Recruit Count: 58

Registration Number: NCT01823900

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer

Phase 3

Conditions: Breast Cancer

Interventions: Drug: carboplatin

First Posted Date: 2012-12-19

Last Posted Date: 2012-12-25

Lead Sponsor: Severance Hospital

Target Recruit Count: 587

Registration Number: NCT01752686

The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation Under Propofol-remifentanil Anesthesia in Elderly Patients

Not Applicable

Completed

Conditions: General Surgery With Endotracheal Intubation

Interventions: Drug: remifentanil

First Posted Date: 2012-11-02

Last Posted Date: 2013-06-18

Lead Sponsor: Severance Hospital

Target Recruit Count: 50

Registration Number: NCT01720498

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Conditions: NSCLC

First Posted Date: 2012-10-02

Last Posted Date: 2012-10-02

Lead Sponsor: Severance Hospital

Target Recruit Count: 155

Registration Number: NCT01697163

Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation

Not Applicable

Completed

Conditions: Kidney Transplantation

Interventions: Drug: Nefopam
Drug: Normal saline

First Posted Date: 2012-06-19

Last Posted Date: 2013-08-20

Lead Sponsor: Severance Hospital

Target Recruit Count: 98

Registration Number: NCT01622881

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Effect of Dexmedetomidine in the Management of Pain After Uterine Artery Embolization

Not Applicable

Completed

Conditions: Pain Control

Interventions: Drug: Normal saline 0.9%
Drug: Dexmedetomidine

First Posted Date: 2012-04-16

Last Posted Date: 2018-01-17

Lead Sponsor: Severance Hospital

Target Recruit Count: 66

Registration Number: NCT01578174

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy